IMPROVEMENT OF METHODS OF TREATMENT OF PERSISTENT ATRIAL FIBRILLATION IN PATIENTS WITH ISCHEMIC HEART DISEASE

Rizayeva Malika Jamolovna

doi:10.17605/OSF.IO/ZFJW9

Authors

Rizayeva Malika Jamolovna Assistant of the Department of Surgical Diseases of Bukhara State Medical Institute

DOI:

https://doi.org/10.17605/OSF.IO/ZFJW9

Keywords:

atrial fibrillation, Electrical cardioversion, verapamil, decompensation, thiazolidinediones, surgical treatment.

Abstract

Atrial fibrillation is the most common arrhythmia encountered in clinical practice and accounts for approximately one third of hospitalizations for cardiac arrhythmias. Cardiac dysfunction may result from myocardial ischemia, rhythm disturbances, valve dysfunction, pericardial damage, increased filling pressure or systemic resistance. Newly developed acute heart failure is most often observed in patients with acute coronary syndrome. The development of decompensation of chronic heart failure is facilitated by low adherence to treatment, fluid overload, infections, alcohol consumption, certain drugs (for example, non-steroidal anti-inflammatory drugs or thiazolidinediones, which cause fluid retention), etc. Acute heart failure is usually accompanied by congestion of blood in the lungs, although in some patients the clinical picture is dominated by signs of decreased cardiac output and tissue hypoperfusion.

Downloads

Download data is not yet available.

References

Berpgein L.L., Novikov V.I., Grishkin Yu.N. Evaluation of the effectiveness of reperfusion in acute myocardial infarction: modern concepts and methods. Grew up. cardiol. zhurn. 2005; 1 (51): 73-79.

Fighters SA Pulmonary edema. Heart 2003; 2 # 1: 38-43.

Gratsianskiy H.A. Atorvastatin: Test results with low baseline cholesterol were found in low-density proteins. Consilium medicum. 2005; 11: 903-12.

Gratsianskiy H.A. Modern treatment of acute coronary syndrome without elevations segment Journal "Difficult patient" / Archive / №3-2007.

Dovgalevskiy submarine. Acute coronary syndrome - pathogenesis, clinical picture, aspects of treatment. What do we know and what needs to be done? Heart. 2002; 1 (1): 13-15.

Zhdanov B.C., Vikhert A.M. Coronary artery thrombosis in myocardial infarction. Arch. Patol. 1981; 10: 40-45.

Journal of atherothrombosis №1 (2) 2009. Independent register OKS RECORD. Patient characteristics and treatment before discharge from the hospital. Erlich A.D., Gratsianskiy H.A.

Ivanov G.G., Grachev C.B., Syrkin A.JI. High resolution electrocardiography. M., Triada-X, 2003.

Mareev V. Yu. The role of lowering cholesterol levels in improving the prognosis of patients with myocardial infarction. RMJ 1999; 7; No. 15: 23-5.

Melent'ev A.C., Gasilin B.C., Gusev E.I. and other Geriatric aspects of internal diseases. M., 1995; from. 394.

Moiseev V.S., Kobalava Zh.D. Cardiorenal syndrome (renal factor and increased risk of cardiovascular disease. Clinical Pharmacology and Therapy 2002; No. 3: 16-18.

Moiseev B.C. Acute heart failure. New treatment options with levosimendan calcium sensitizer. Pharma Press, 2004.

Schaufelberger M, Swedberg K, Koster M, et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 2004 Feb;25(4):300-7.

Sadowski M. J., Pankiewicz J., Scholtzova H.et al. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach,for Alzheimer's disease. ProcNatl Acad Sci.U S A. 2006:103:18787-92.